{"protocolSection": {"identificationModule": {"nctId": "NCT00273182", "orgStudyIdInfo": {"id": "187"}, "organization": {"fullName": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}, "briefTitle": "InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Registry", "officialTitle": "InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) Systems for Cardiac Resynchronization Therapy (CRT) - InSync Registry"}, "statusModule": {"statusVerifiedDate": "2013-07", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2002-03"}, "primaryCompletionDateStruct": {"date": "2011-04", "type": "ACTUAL"}, "completionDateStruct": {"date": "2011-04", "type": "ACTUAL"}, "studyFirstSubmitDate": "2006-01-04", "studyFirstSubmitQcDate": "2006-01-04", "studyFirstPostDateStruct": {"date": "2006-01-09", "type": "ESTIMATED"}, "resultsFirstSubmitDate": "2012-04-13", "resultsFirstSubmitQcDate": "2013-07-01", "resultsFirstPostDateStruct": {"date": "2013-08-05", "type": "ESTIMATED"}, "lastUpdateSubmitDate": "2013-07-01", "lastUpdatePostDateStruct": {"date": "2013-08-05", "type": "ESTIMATED"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Medtronic Cardiac Rhythm and Heart Failure", "class": "INDUSTRY"}}, "oversightModule": {"oversightHasDmc": false}, "descriptionModule": {"briefSummary": "Heart failure is a progressive disease that decreases the pumping action of the heart. This may cause a backup of fluid in the heart and may result in heart beat changes.\n\nWhen there are changes in the heart beat sometimes an implantable heart device is used to control the rate and rhythm of the heart beat. In certain heart failure cases, when the two lower chambers of the heart no longer beat in a coordinated manner, cardiac resynchronization therapy (CRT) may be prescribed. CRT is similar to a pacemaker. It is placed (implanted) under the skin of the upper chest. CRT is delivered as tiny electrical pulses to the right and left ventricles through three or four leads (soft insulated wires) that are inserted through the veins to the heart.\n\nThe purpose of this study is to monitor the long-term performance of the InSync Model 8040 (InSync) and InSync III Model 8042 (InSync III) systems for cardiac resynchronization therapy (CRT).", "detailedDescription": "Condition of Approval study for cardiac resynchronization therapy with pacemakers, and for the Attain left ventricular leads 2187, 2188, 4193, and 4194."}, "conditionsModule": {"conditions": ["Heart Failure", "Cardiomyopathy"], "keywords": ["Heart Failure", "Cardiomyopathy", "Cardiac pacing", "Cardiac resynchronization therapy"]}, "designModule": {"studyType": "OBSERVATIONAL", "patientRegistry": false, "designInfo": {"observationalModel": "COHORT", "timePerspective": "PROSPECTIVE"}, "enrollmentInfo": {"count": 1999, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Cohort", "description": "Patients implanted with InSync Model 8040, InSync III Model 8042 , or Medtronic CRT-D system. A total of 1999 subjects were enrolled in the study. Of them, 1738 had successful post market implants of InSync Model 8040 (601 subjects), InSync III Model 8042 (512 subjects) and CRT-D devices (625 subjects). The rest 262 subjects came from two pre-market studies: the MIRACLE study added 141 subjects to InSync Model 8040, and the InSync III study added 121 subjects to the InSync III Model 8042. A total of 1014 subjects completed the study through 36 month follow up. Follow-up of 1000 subjects was required by the FDA to satisfy the conditions of approval.", "interventionNames": ["Device: InSync Model 8040", "Device: InSync III Model 8042"]}], "interventions": [{"type": "DEVICE", "name": "InSync Model 8040", "description": "Subjects with sucessful implants of InSync Model 8040.", "armGroupLabels": ["Cohort"]}, {"type": "DEVICE", "name": "InSync III Model 8042", "description": "Subjects with successful implants of InSync III Model 8042", "armGroupLabels": ["Cohort"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Overall Death Rate and Cause Specific Death Rate During Three Years Post Implant.", "description": "Survival curves of overall mortality and cause specific mortality (due to progressive heart failure and sudden cardiac death) were created based on Kaplan-Meier estimates. Estimates went out to 36 month time point. Confidence intervals were calculated on a log-log scale. The Kaplan-Meier estimates are reported in the statistical analysis modules", "timeFrame": "36 month follow-up"}], "secondaryOutcomes": [{"measure": "Left Ventricular (LV) Lead R-wave Amplitude", "description": "Summary statistics such as mean and 95% CI for the LV lead R-wave amplitude during the 36 months of follow-up.", "timeFrame": "36 month follow-up"}, {"measure": "Left Ventricular (LV) Lead Impedance", "description": "Summary statistics such as mean and 95% CI for the LV lead impedance during the 36 months of follow-up.", "timeFrame": "36 months follow-up"}, {"measure": "Left Ventricular (LV) Lead Pacing Voltage Threshold", "description": "Summary statistics such as mean and 95% CI for the LV lead pacing voltage threshold during the 36 months of follow-up", "timeFrame": "36 months follow-up"}, {"measure": "Subjects With Left Ventricular (LV) Lead Related Complications During Three Years Post-implant", "description": "A left ventricular lead related complication is defined as an adverse event that requires invasive intervention or leads to loss of significant device function resulting from the presence or performance of the LV lead.\n\nKaplan-Meier method was used to estimate complication-free rate during the three years of follow-up. Time to the first post-implant LV lead related complication was used for the calculation. Confidence intervals were calculated on a log-log scale.", "timeFrame": "36 months follow-up"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Patients implanted with an InSync Model 8040 or InSync III Model 8042, a right ventricular lead, and a Medtronic market-released left ventricular lead as part of a system to deliver cardiac resynchronization therapy.\n\nExclusion Criteria:\n\n* Patients with a history of a previously failed placement of a currently investigational Medtronic left ventricular lead within 30 days of enrollment in the InSync Registry", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "18 Years", "stdAges": ["ADULT", "OLDER_ADULT"], "studyPopulation": "Patients indicated for use of a cardiac device", "samplingMethod": "NON_PROBABILITY_SAMPLE"}, "contactsLocationsModule": {"overallOfficials": [{"name": "InSync Registry Study Leader", "affiliation": "Medtronic", "role": "STUDY_CHAIR"}], "locations": [{"city": "Birmingham", "state": "Alabama", "country": "United States", "geoPoint": {"lat": 33.52066, "lon": -86.80249}}, {"city": "Peoria", "state": "Arizona", "country": "United States", "geoPoint": {"lat": 33.5806, "lon": -112.23738}}, {"city": "Ft. Smith", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 35.38592, "lon": -94.39855}}, {"city": "Little Rock", "state": "Arkansas", "country": "United States", "geoPoint": {"lat": 34.74648, "lon": -92.28959}}, {"city": "Long Beach", "state": "California", "country": "United States", "geoPoint": {"lat": 33.76696, "lon": -118.18923}}, {"city": "Napa", "state": "California", "country": "United States", "geoPoint": {"lat": 38.29714, "lon": -122.28553}}, {"city": "Oxnard", "state": "California", "country": "United States", "geoPoint": {"lat": 34.1975, "lon": -119.17705}}, {"city": "San Diego", "state": "California", "country": "United States", "geoPoint": {"lat": 32.71533, "lon": -117.15726}}, {"city": "Yuba City", "state": "California", "country": "United States", "geoPoint": {"lat": 39.14045, "lon": -121.61691}}, {"city": "Washington D.C.", "state": "District of Columbia", "country": "United States", "geoPoint": {"lat": 38.89511, "lon": -77.03637}}, {"city": "Gainesville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 29.65163, "lon": -82.32483}}, {"city": "Jacksonville", "state": "Florida", "country": "United States", "geoPoint": {"lat": 30.33218, "lon": -81.65565}}, {"city": "Jupiter", "state": "Florida", "country": "United States", "geoPoint": {"lat": 26.93422, "lon": -80.09421}}, {"city": "Melbourne", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.08363, "lon": -80.60811}}, {"city": "Miami", "state": "Florida", "country": "United States", "geoPoint": {"lat": 25.77427, "lon": -80.19366}}, {"city": "Orlando", "state": "Florida", "country": "United States", "geoPoint": {"lat": 28.53834, "lon": -81.37924}}, {"city": "Tampa", "state": "Florida", "country": "United States", "geoPoint": {"lat": 27.94752, "lon": -82.45843}}, {"city": "Atlanta", "state": "Georgia", "country": "United States", "geoPoint": {"lat": 33.749, "lon": -84.38798}}, {"city": "Rockford", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 42.27113, "lon": -89.094}}, {"city": "Springfield", "state": "Illinois", "country": "United States", "geoPoint": {"lat": 39.80172, "lon": -89.64371}}, {"city": "Indianapolis", "state": "Indiana", "country": "United States", "geoPoint": {"lat": 39.76838, "lon": -86.15804}}, {"city": "Des Moines", "state": "Iowa", "country": "United States", "geoPoint": {"lat": 41.60054, "lon": -93.60911}}, {"city": "Kansas City", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 39.11417, "lon": -94.62746}}, {"city": "Overland Park", "state": "Kansas", "country": "United States", "geoPoint": {"lat": 38.98223, "lon": -94.67079}}, {"city": "Lexington", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 37.98869, "lon": -84.47772}}, {"city": "Louisville", "state": "Kentucky", "country": "United States", "geoPoint": {"lat": 38.25424, "lon": -85.75941}}, {"city": "Lake Charles", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 30.21309, "lon": -93.2044}}, {"city": "Shreveport", "state": "Louisiana", "country": "United States", "geoPoint": {"lat": 32.52515, "lon": -93.75018}}, {"city": "Baltimore", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 39.29038, "lon": -76.61219}}, {"city": "Salisbury", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.36067, "lon": -75.59937}}, {"city": "Silver Spring", "state": "Maryland", "country": "United States", "geoPoint": {"lat": 38.99067, "lon": -77.02609}}, {"city": "Boston", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.35843, "lon": -71.05977}}, {"city": "Worchester", "state": "Massachusetts", "country": "United States", "geoPoint": {"lat": 42.26259, "lon": -71.80229}}, {"city": "Detroit", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.33143, "lon": -83.04575}}, {"city": "Kalamazoo", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.29171, "lon": -85.58723}}, {"city": "Lansing", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 42.73253, "lon": -84.55553}}, {"city": "Marquette", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 46.54354, "lon": -87.39542}}, {"city": "Saginaw", "state": "Michigan", "country": "United States", "geoPoint": {"lat": 43.41947, "lon": -83.95081}}, {"city": "Duluth", "state": "Minnesota", "country": "United States", "geoPoint": {"lat": 46.78327, "lon": -92.10658}}, {"city": "Minneapolis", "state": "Minnesota", "country": "United States", "geoPoint": {"lat": 44.97997, "lon": -93.26384}}, {"city": "Hattiesburg", "state": "Mississippi", "country": "United States", "geoPoint": {"lat": 31.32712, "lon": -89.29034}}, {"city": "Tupelo", "state": "Mississippi", "country": "United States", "geoPoint": {"lat": 34.25807, "lon": -88.70464}}, {"city": "Columbia", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.95171, "lon": -92.33407}}, {"city": "Kansas City", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 39.09973, "lon": -94.57857}}, {"city": "Springfield", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 37.21533, "lon": -93.29824}}, {"city": "St. Joseph", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 39.76861, "lon": -94.84663}}, {"city": "St. Louis", "state": "Missouri", "country": "United States", "geoPoint": {"lat": 38.62727, "lon": -90.19789}}, {"city": "Billings", "state": "Montana", "country": "United States", "geoPoint": {"lat": 45.78329, "lon": -108.50069}}, {"city": "Lincoln", "state": "Nebraska", "country": "United States", "geoPoint": {"lat": 40.8, "lon": -96.66696}}, {"city": "Newark", "state": "New Jersey", "country": "United States", "geoPoint": {"lat": 40.73566, "lon": -74.17237}}, {"city": "Manhasset", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.79788, "lon": -73.69957}}, {"city": "New York", "state": "New York", "country": "United States", "geoPoint": {"lat": 40.71427, "lon": -74.00597}}, {"city": "Rochester", "state": "New York", "country": "United States", "geoPoint": {"lat": 43.15478, "lon": -77.61556}}, {"city": "Chapel Hill", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.9132, "lon": -79.05584}}, {"city": "Charlotte", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.22709, "lon": -80.84313}}, {"city": "High Pointe", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.95569, "lon": -80.00532}}, {"city": "Raleigh", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 35.7721, "lon": -78.63861}}, {"city": "Winston-Salem", "state": "North Carolina", "country": "United States", "geoPoint": {"lat": 36.09986, "lon": -80.24422}}, {"city": "Cincinnati", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.12713, "lon": -84.51435}}, {"city": "Cleveland", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.4995, "lon": -81.69541}}, {"city": "Columbus", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 39.96118, "lon": -82.99879}}, {"city": "Mayfield Heights", "state": "Ohio", "country": "United States", "geoPoint": {"lat": 41.51922, "lon": -81.4579}}, {"city": "Oklahoma City", "state": "Oklahoma", "country": "United States", "geoPoint": {"lat": 35.46756, "lon": -97.51643}}, {"city": "Doylestown", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 40.31011, "lon": -75.12989}}, {"city": "Erie", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 42.12922, "lon": -80.08506}}, {"city": "Philadelphia", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.95233, "lon": -75.16379}}, {"city": "York", "state": "Pennsylvania", "country": "United States", "geoPoint": {"lat": 39.9626, "lon": -76.72774}}, {"city": "Providence", "state": "Rhode Island", "country": "United States", "geoPoint": {"lat": 41.82399, "lon": -71.41283}}, {"city": "Greenville", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 34.85262, "lon": -82.39401}}, {"city": "Spartanburg", "state": "South Carolina", "country": "United States", "geoPoint": {"lat": 34.94957, "lon": -81.93205}}, {"city": "Nashville", "state": "Tennessee", "country": "United States", "geoPoint": {"lat": 36.16589, "lon": -86.78444}}, {"city": "Dallas", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.78306, "lon": -96.80667}}, {"city": "Ft. Worth", "state": "Texas", "country": "United States", "geoPoint": {"lat": 32.72541, "lon": -97.32085}}, {"city": "Houston", "state": "Texas", "country": "United States", "geoPoint": {"lat": 29.76328, "lon": -95.36327}}, {"city": "Lubbock", "state": "Texas", "country": "United States", "geoPoint": {"lat": 33.57786, "lon": -101.85517}}, {"city": "Sherman", "state": "Texas", "country": "United States", "geoPoint": {"lat": 33.63566, "lon": -96.60888}}, {"city": "Salt Lake City", "state": "Utah", "country": "United States", "geoPoint": {"lat": 40.76078, "lon": -111.89105}}, {"city": "Richmond", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 37.55376, "lon": -77.46026}}, {"city": "Virginia Beach", "state": "Virginia", "country": "United States", "geoPoint": {"lat": 36.85293, "lon": -75.97799}}, {"city": "Seattle", "state": "Washington", "country": "United States", "geoPoint": {"lat": 47.60621, "lon": -122.33207}}, {"city": "Morgantown", "state": "West Virginia", "country": "United States", "geoPoint": {"lat": 39.62953, "lon": -79.9559}}, {"city": "Milwaukee", "state": "Wisconsin", "country": "United States", "geoPoint": {"lat": 43.0389, "lon": -87.90647}}]}, "referencesModule": {"references": [{"pmid": "19719485", "type": "DERIVED", "citation": "Johnson WB, Abraham WT, Young JB, Wheelan K, Smith AL, Chang Y, Brinkman P; InSync Registry Investigators. Long-term performance of the attain model 4193 left ventricular lead. Pacing Clin Electrophysiol. 2009 Sep;32(9):1111-6. doi: 10.1111/j.1540-8159.2009.02451.x."}]}}, "resultsSection": {"participantFlowModule": {"preAssignmentDetails": "1999 subjects were enrolled in the study. Of them 1738 had successful post market implants of InSync Model 8040 (n=601), InSync III Model 8042 (n=512) and CRT-D devices (n=625). The rest 262 subjects came from two pre-market studies: MIRACLE study added 141 subjects to InSync Model 8040, InSync III study added 121 to InSync III Model 8042.", "recruitmentDetails": "The InSync Registry commenced subject enrollment on February 27, 2002. A total of 1999 subjects were enrolled in the study during the time period of February 2002 through February 2008. 1014 subjects completed the study through 36 month follow up. Follow-up of 1000 subjects was required by the FDA to satisfy the conditions of approval.", "groups": [{"id": "FG000", "title": "All Subjects", "description": "Patients successfully implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "1999"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "1014"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "985"}]}], "dropWithdraws": [{"type": "Death", "reasons": [{"groupId": "FG000", "numSubjects": "450"}]}, {"type": "Lost to Follow-up", "reasons": [{"groupId": "FG000", "numSubjects": "88"}]}, {"type": "Withdrawal by Subject", "reasons": [{"groupId": "FG000", "numSubjects": "257"}]}, {"type": "Device/System Explant", "reasons": [{"groupId": "FG000", "numSubjects": "154"}]}, {"type": "Site exit, system change, 36 m FU missed", "reasons": [{"groupId": "FG000", "numSubjects": "36"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "All Subjects", "description": "Patients implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "1999"}]}], "measures": [{"title": "Age, Categorical", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "<=18 years", "measurements": [{"groupId": "BG000", "value": "0"}]}, {"title": "Between 18 and 65 years", "measurements": [{"groupId": "BG000", "value": "686"}]}, {"title": ">=65 years", "measurements": [{"groupId": "BG000", "value": "1313"}]}]}]}, {"title": "Age Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"categories": [{"measurements": [{"groupId": "BG000", "value": "67.2", "spread": "12.7"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "728"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "1271"}]}]}]}, {"title": "Region of Enrollment", "paramType": "NUMBER", "unitOfMeasure": "participants", "classes": [{"title": "United States", "categories": [{"measurements": [{"groupId": "BG000", "value": "1999"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Overall Death Rate and Cause Specific Death Rate During Three Years Post Implant.", "description": "Survival curves of overall mortality and cause specific mortality (due to progressive heart failure and sudden cardiac death) were created based on Kaplan-Meier estimates. Estimates went out to 36 month time point. Confidence intervals were calculated on a log-log scale. The Kaplan-Meier estimates are reported in the statistical analysis modules", "populationDescription": "The analysis included data from all subjects enrolled in the InSync Registry study and successfully implanted with the InSync or InSync III system.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "36 month follow-up", "groups": [{"id": "OG000", "title": "All Subjects", "description": "Patients successfully implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1999"}]}], "classes": [{"title": "Overall Death", "categories": [{"measurements": [{"groupId": "OG000", "value": "450"}]}]}, {"title": "Cause Specific Death", "categories": [{"measurements": [{"groupId": "OG000", "value": "213"}]}]}], "analyses": [{"groupIds": ["OG000"], "groupDescription": "For overall mortality, the endpoint is the proportion of subjects alive during three years post-implant. Survival curves of overall mortality and cause-specific mortality were created based on Kaplan-Meier (product limit) estimates. Confidence intervals will be calculated on a log-log scale.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValueComment": "No p values for the analysis.", "statisticalMethod": "Kaplan-Meier (product limit) estimates", "statisticalComment": "Survival curves of cause-specific mortality were created based on Kaplan-Meier (product limit) estimates.", "paramType": "Overall survival rate at 36 month", "paramValue": "71.0", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "68.6", "ciUpperLimit": "73.2", "estimateComment": "The estimate is the overall survival rate at 36 month. left-truncation methods were used in the survival analysis for previously implanted subjects."}, {"groupIds": ["OG000"], "groupDescription": "For cause-specific mortality, the endpoint is the proportion of patients who are alive or do not die due to the progressive heart failure or sudden cardiac death causes during 3 years post-implant. Survival curves of cause-specific mortality were created based on Kaplan-Meier (product limit) estimates. Confidence intervals were calculated on a log-log scale.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValueComment": "No p value for this analysis.", "statisticalMethod": "Kaplan-Meier (product limit) estimates", "statisticalComment": "Cause specific survival rate at 36 month.", "paramType": "Cause specific survival rate at 36 month", "paramValue": "85.3", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "83.3", "ciUpperLimit": "87.1", "estimateComment": "left-truncation methods were used in the survival analysis for previously implanted subjects."}]}, {"type": "SECONDARY", "title": "Left Ventricular (LV) Lead R-wave Amplitude", "description": "Summary statistics such as mean and 95% CI for the LV lead R-wave amplitude during the 36 months of follow-up.", "populationDescription": "1999 subjects successfully implanted with a left ventricular lead as part of a Medtronic CRT/CRT-D system.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "mV", "timeFrame": "36 month follow-up", "groups": [{"id": "OG000", "title": "All Subjects", "description": "Patients successfully implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1999"}]}], "classes": [{"title": "6 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.7", "lowerLimit": "13.4", "upperLimit": "14.1"}]}]}, {"title": "12 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.3", "lowerLimit": "13.0", "upperLimit": "13.7"}]}]}, {"title": "18 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.2", "lowerLimit": "12.8", "upperLimit": "13.6"}]}]}, {"title": "24 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.2", "lowerLimit": "12.8", "upperLimit": "13.6"}]}]}, {"title": "30 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.4", "lowerLimit": "13.0", "upperLimit": "13.8"}]}]}, {"title": "36 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "13.6", "lowerLimit": "13.1", "upperLimit": "14.1"}]}]}]}, {"type": "SECONDARY", "title": "Left Ventricular (LV) Lead Impedance", "description": "Summary statistics such as mean and 95% CI for the LV lead impedance during the 36 months of follow-up.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "ohms", "timeFrame": "36 months follow-up", "groups": [{"id": "OG000", "title": "All Subjects", "description": "Patients implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1999"}]}], "classes": [{"title": "6 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "620", "lowerLimit": "609", "upperLimit": "630"}]}]}, {"title": "12 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "625", "lowerLimit": "613", "upperLimit": "636"}]}]}, {"title": "18 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "628", "lowerLimit": "615", "upperLimit": "641"}]}]}, {"title": "24 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "622", "lowerLimit": "608", "upperLimit": "635"}]}]}, {"title": "30 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "632", "lowerLimit": "617", "upperLimit": "646"}]}]}, {"title": "36 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "633", "lowerLimit": "619", "upperLimit": "648"}]}]}]}, {"type": "SECONDARY", "title": "Left Ventricular (LV) Lead Pacing Voltage Threshold", "description": "Summary statistics such as mean and 95% CI for the LV lead pacing voltage threshold during the 36 months of follow-up", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "95% Confidence Interval", "unitOfMeasure": "Volts", "timeFrame": "36 months follow-up", "groups": [{"id": "OG000", "title": "All Subjects", "description": "Patients implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1999"}]}], "classes": [{"title": "6 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.70", "lowerLimit": "1.63", "upperLimit": "1.77"}]}]}, {"title": "12 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.65", "lowerLimit": "1.59", "upperLimit": "1.72"}]}]}, {"title": "18 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.69", "lowerLimit": "1.62", "upperLimit": "1.77"}]}]}, {"title": "24 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.72", "lowerLimit": "1.64", "upperLimit": "1.81"}]}]}, {"title": "30 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.76", "lowerLimit": "1.67", "upperLimit": "1.85"}]}]}, {"title": "36 months follow-up", "categories": [{"measurements": [{"groupId": "OG000", "value": "1.76", "lowerLimit": "1.67", "upperLimit": "1.85"}]}]}]}, {"type": "SECONDARY", "title": "Subjects With Left Ventricular (LV) Lead Related Complications During Three Years Post-implant", "description": "A left ventricular lead related complication is defined as an adverse event that requires invasive intervention or leads to loss of significant device function resulting from the presence or performance of the LV lead.\n\nKaplan-Meier method was used to estimate complication-free rate during the three years of follow-up. Time to the first post-implant LV lead related complication was used for the calculation. Confidence intervals were calculated on a log-log scale.", "populationDescription": "The analysis included data from all subjects enrolled in the InSync Registry study.", "reportingStatus": "POSTED", "paramType": "NUMBER", "unitOfMeasure": "participants", "timeFrame": "36 months follow-up", "groups": [{"id": "OG000", "title": "All Subjects", "description": "Patients successfully implanted with InSync Model 8040 (including post-market new implants of InSync Model 8040 and pre-market implants from the MIRACLE study), InSync III Model 8042 (including post-market new implants of InSync III Model 8042 and pre-market implants from the InSync III study), and post-market Medtronic CRT-D devices."}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "1999"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "176"}]}]}], "analyses": [{"groupIds": ["OG000"], "groupDescription": "Kaplan-Meier (product limit) estimate of the curve representing the time to first post-implant LV lead related complication were calculated to the first time point where fewer than 50 patients are still at risk. Confidence intervals will be calculated on a log-log scale.", "testedNonInferiority": false, "nonInferiorityType": "SUPERIORITY_OR_OTHER", "pValueComment": "No p value for this analysis.", "statisticalMethod": "Kaplan-Meier (product limit) estimate", "paramType": "event free rate", "paramValue": "89.8", "ciPctValue": "95", "ciNumSides": "TWO_SIDED", "ciLowerLimit": "88.3", "ciUpperLimit": "91.2"}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "36 months", "eventGroups": [{"id": "EG000", "title": "All Patients", "description": "The analysis included data from all subjects enrolled in the InSync Registry study.", "seriousNumAffected": 450, "seriousNumAtRisk": 1999, "otherNumAffected": 175, "otherNumAtRisk": 1999}], "seriousEvents": [{"term": "Death", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Death and adverse events which resulted in hospitalization are listed as serious adverse events. There was no AE resulted in hospitalization in this study.", "stats": [{"groupId": "EG000", "numEvents": 450, "numAffected": 450, "numAtRisk": 1999}]}], "otherEvents": [{"term": "4194 lv lead explanted", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "notes": "Only LV lead related AEs are reported for this study.", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Elevated pacing thresholds", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 18, "numAffected": 18, "numAtRisk": 1999}]}, {"term": "Exit block", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Failure to capture, loss of capture", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 41, "numAffected": 40, "numAtRisk": 1999}]}, {"term": "Heart failure decompensation", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Hypotension", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Lead conductor fracture", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Lead dislodgment", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 75, "numAffected": 70, "numAtRisk": 1999}]}, {"term": "Lead insulation failure", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Muscle stimulation-diaphragm", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 49, "numAffected": 47, "numAtRisk": 1999}]}, {"term": "Other (IPG code)", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Oversensing", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pacemaker mediated tachycardia", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Pocket erosion", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Suboptimal position of 4194 lead", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Unable to defibrillate", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}, {"term": "Undersensing", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 1999}]}, {"term": "Ventricular fibrillation", "organSystem": "General disorders", "assessmentType": "SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 1999}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictionType": "OTHER", "restrictiveAgreement": true, "otherDetails": "In most cases, contracts allow investigators (\"PI\") to publish per the publication strategy/Clinical Investigation Plan following Medtronic's review for (a) disclosure of confidential information (\"CI\"), and (b) selection and order of publications by the publications committee. Any such CI is deleted prior to publication/presentation. Medtronic may not otherwise censor/interfere with the publication. PI's may not publish single-site data until the main multi-site publication has occurred."}, "pointOfContact": {"title": "InSync Registry Clinical Trial Leader", "organization": "Medtronic, Inc.", "email": "medtroniccrmtrials@medtronic.com"}}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000006333", "term": "Heart Failure"}, {"id": "D000009202", "term": "Cardiomyopathies"}], "ancestors": [{"id": "D000006331", "term": "Heart Diseases"}, {"id": "D000002318", "term": "Cardiovascular Diseases"}], "browseLeaves": [{"id": "M9421", "name": "Heart Failure", "asFound": "Heart Failure", "relevance": "HIGH"}, {"id": "M12154", "name": "Cardiomyopathies", "asFound": "Cardiomyopathy", "relevance": "HIGH"}, {"id": "M9419", "name": "Heart Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC14", "name": "Heart and Blood Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}}, "hasResults": true}